Escolar Documentos
Profissional Documentos
Cultura Documentos
articlekey=43323
What are the possible risks and complications of untreated herpes eye infections?
can also affect the eye. Cytomegalovirus causes eye disease in immunocompromised people, such as HIVinfected patients with low T cell counts.
Unfortunately, there is still no antiviral medication that "cures" one of herpes. When we acquire herpes viruses,
they incorporate themselves into the cells in our nervous system where they remain inactive and quiet ("latent")
for months or years. No treatment has been developed to date that can eradicate the viruses when in their latent
state.
When the virus becomes "active" for whatever reason, it begins reproducing and its progeny viruses travel along
a nerve to the site of the infection (at the skin or cornea). The antiviral medications available today only affect
these actively replicating viruses, not the latent viruses in the nervous system.
In addition to antiviral medications, antibiotic drops or ointment might be used preventatively to reduce chances
of a bacterial infection developing in the area of viral infection. This is because when the cornea is eroded, it
becomes more vulnerable to a bacterial infection.
If the eye pressure (intraocular pressure) rises due to internal swelling (inflammation) of the eye or direct herpes
virus infection of the trabecular meshwork (the internal drainage channels within the eye), a pressure-lowering
medication will also be necessary.
Inflammation of any of the tissues of the eye may be so significant as to require anti-inflammatory medications
such as steroids. While steroids can control inflammation very well, they can also compromise the immune
system, so most often they are carefully introduced once the active viruses are well controlled by antiviral
medication. In some cases, the inflammation is chronic or recurring, requiring several rounds of steroid treatment.
What are the possible risks and complications of untreated herpes eye
infections?
In the worst case scenario, untreated herpes eye infections lead to blindness, chronic pain, and loss of the eye.
Aggressive treatment is aimed at reducing the chances of scarring, eye pressure problems, and direct damage to
the eye tissues.
There is no vaccine against HSV at this time. However, there is a vaccine against HZV for children (chickenpox
vaccine) and a vaccine against HZV shingles for adults.
For patients with frequent recurrences of herpes eye infections, taking a low dose antiviral drug on a daily basis
can, in some cases, reduce the frequency of recurrences. Your doctors will help determine if this is a safe option.
For now, each recurring episode needs to be aggressively monitored and treated. Research is ongoing to
develop a means of eradicating the virus in its latent state.
REFERENCES:
van Rooij, J., et al. "Effect of acyclovir after penetrating keratoplasty for herpatic keratitis: a placebo-controlled
multicenter trial." Ophthalmology 110.10 (2003): 1916-1919.
Farooq, A. V., et al. "Herpes simplex epithelial and stromal keratitis: an epidemiologic update." Survey of
Ophthalmology 57.5 (2012): 448-462.
Liesegang, T. J. "Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity." 115.2
Suppl (2008) :S3-S12.